Navigation

Lodine

  • Generic Name: etodolac
  • Brand Name: Lodine

Lodine (Etodolac) side effects drug center

  • Related Drugs
    Ansaid Arthrotec Azasan Bextra Celebrex Clinoril Darvon Daypro Alta Diclostream Dilaudid Dolobid Duexis Duragesic Enbrel Feldene Flector Patch Humira Imuran Indocin Kenalog 10 Injection Medrol Mobic Nalfon Naprelan Naprosyn Opana ER Orencia Orudis Relafen Remicade Ridaura Sandimmune Simponi Synvisc Synvisc-One Tolectin Ultram Ultram ER Vimovo Voltaren
  • Health Resources
    Ankle Pain (Tendonitis) Ankylosing Spondylitis Gout Psoriatic Arthritis Rheumatoid Arthritis (RA)
  • Related Supplements
    Avocado Beta-Carotene Borage Bovine Cartilage Bromelain Camphor Capsicum Cat's Claw Cetylated Fatty Acids Chondroitin Sulfate Devil's Claw Fish Oil Gamma Linolenic Acid Glucosamine Sulfate Hyaluronic Acid Rutin Same Soybean Oil Superoxide Dismutase Thunder God Vine Trypsin Vitamin D Vitamin E
  • Drug Comparison
    Relafen vs. Lodine

    •  

    PROFESSIONAL

    CONSUMER

    SIDE EFFECTS

     

    Lodine Side Effects Center

    What Is Lodine?

    Lodine (etodolac) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis, rheumatoid arthritis, and acute pain. The brand name Lodine is no longer available in the U.S. Lodine is available as a generic.

    What Are Side Effects of Lodine?

    Common side effects of Lodine (etodolac) include:

    Serious side effects of Lodine include:

    Dosage for Lodine

    Lodine is available in capsules at strengths of 200 and 300 mg, and as tablets at strengths of 400 and 500 mg. Usual dosage is 200-400 mg every 6 to 8 hours, not to exceed 1000 mg. Patients with asthma that are aspirin-sensitive should avoid use of this Lodine.

    What Drugs, Substances, or Supplements Interact with Lodine?

    Lodine may reduce the effectiveness of ACE inhibitors and increase lithium (Eskalith, Lithobid) levels; use with aspirin or similar agents is not recommended. Caution is advised as Lodine may react with a number of other drugs so the prescribing physician will need a list of current medications. Lodine may interact with ACE inhibitors, aspirin or other NSAIDs, cyclosporine, digoxin, methotrexate, diuretics (water pills), lithium, phenylbutazone, antidepressants, steroids, and blood thinners. Tell your doctor all medications and supplements you use.

    Lodine During Pregnancy and Breastfeeding

    Tell your doctor if you are pregnant or plan to become pregnant during treatment with Lodine; taking Lodine during the last 3 months of pregnancy may harm the fetus. Do not take Lodine during pregnancy unless your doctor has told you to. It is unknown if Lodine passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding. Safety and effectiveness in pediatric patients below the age of 18 years have not been established for Lodine.

    Additional Information

    Our Lodine Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

     

    Lodine Consumer Information

    Get emergency medical help if you have signs of an allergic reaction (hives, runny or stuffy nose, wheezing, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

    Get emergency medical help if you have signs of a heart attack or stroke: chest pain spreading to your jaw or shoulder, sudden numbness or weakness on one side of the body, slurred speech, swelling in your legs, feeling short of breath.

    Stop using etodolac and call your doctor at once if you have:

    • changes in your vision;
    • any skin rash, no matter how mild;
    • shortness of breath (even with mild exertion);
    • swelling or rapid weight gain;
    • signs of stomach bleeding--bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;
    • liver problems--nausea, upper stomach pain, itching, tired feeling, flu-like symptoms, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
    • kidney problems--little or no urination, swelling in your feet or ankles, feeling tired; or
    • low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed, cold hands and feet.

    Common side effects may include:

    • nausea, vomiting, stomach pain, indigestion;
    • diarrhea, constipation, gas;
    • dizziness, headache, tired feeling;
    • rash; or
    • ringing in your ears.

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Read the entire detailed patient monograph for Lodine (Etodolac)

     

    Lodine Professional Information

    SIDE EFFECTS

    In patients taking etodolac or other NSAIDs, the most frequently reported adverse experiences occurring in approximately 1 to 10% of patients are:

    Gastrointestinal experiences including: abdominal pain, constipation, diarrhea, dyspepsia, flatulence, gross bleeding/perforation, heartburn, nausea, GI ulcers (gastric/duodenal), vomiting.

    Other events including: abnormal renal function, anemia, dizziness, edema, elevated liver enzymes, headaches, increased bleeding time, pruritis, rashes, tinnitus.

    Adverse-reaction information for etodolac was derived from 2,629 arthritic patients treated with etodolac capsules and tablets in double-blind and open-label clinical trials of 4 to 320 weeks in duration and worldwide postmarketing surveillance studies. In clinical trials, most adverse reactions were mild and transient. The discontinuation rate in controlled clinical trials, because of adverse events, was up to 10% for patients treated with etodolac.

    New patient complaints (with an incidence greater than or equal to 1%) are listed below by body system. The incidences were determined from clinical trials involving 465 patients with osteoarthritis treated with 300 to 500 mg of etodolac b.i.d. (i.e., 600 to 1000 mg/day). Incidence Greater That or Equal to 1% - Probably Causally Related

    Body as a whole - Chills and fever.

    Digestive system - Dyspepsia (10%), abdominal pain*5, diarrhea*5, flatulence*5, nausea*5, constipation, gastritis, melena, vomiting.

    Nervous system - Asthenia/malaise*5, dizziness*5, depression, nervousness.

    Skin and appendages - Pruritus, rash.

    Special senses - Blurred vision, tinnitus.

    Urogenital system - Dysuria, urinary frequency.

    Drug-related patient complaints occurring in fewer than 3%, but more than 1%, are unmarked. 5*Drug-related patient complaints occurring in 3 to 9% of patients treated with etodolac. Incidence Less Than 1% - Probably Causally Related

    (Adverse reactions reported only in worldwide postmarketing experience, not seen in clinical trials, are considered rarer and are italicized)

    Body as a whole - Allergic reaction, anaphylactic/anaphylactoid reactions (including shock).

    Cardiovascular system - Hypertension, congestive heart failure, flushing, palpitations, syncope, vasculitis (including necrotizing and allergic).

    Digestive system - Thirst, dry mouth, ulcerative stomatitis, anorexia, eructation, elevated liver enzymes, cholestatic hepatitis, hepatitis, cholestatic jaundice, duodenitis, jaundice, hepatic failure, liver necrosis, peptic ulcer with or without bleeding and/or perforation, intestinal ulceration, pancreatitis.

    Hemic and lymphatic system - Ecchymosis, anemia, thrombocytopenia, bleeding time increased, agranulocytosis, hemolytic anemia, leukopenia, neutropenia, pancytopenia.

    Metabolic and nutritional - Edema, serum creatinine increase, hyperglycemia in previously controlled diabetic patients.

    Nervous system - Insomnia, somnolence.

    Respiratory system - Asthma, pulmonary infiltration with eosinophilia.

    Skin and appendages - Angioedema, sweating, urticaria, vesiculobullous rash, cutaneous vasculitis with purpura, Stevens-Johnson Syndrome, toxic epidermal necrolysis, hyperpigmentation, erythema multiforme.

    Special senses - Photophobia, transient visual disturbances.

    Urogenital system - Elevated BUN, renal failure, renal insufficiency, renal papillary necrosis.

    Incidence Less Than 1% - Causal Relationship Unknown

    (Medical events occurring under circumstances where causal relationship to etodolac is uncertain. These reactions are listed as alerting information for physicians)

    Body as a whole - Infection, headache.

    Cardiovascular system - Arrhythmias, myocardial infarction, cerebrovascular accident.

    Digestive system - Esophagitis with or without stricture or cardiospasm, colitis.

    Metabolic and nutritional - Change in weight.

    Nervous system - Paresthesia, confusion.

    Respiratory system - Bronchitis, dyspnea, pharyngitis, rhinitis, sinusitis.

    Skin and appendages - Alopecia, maculopapular rash, photosensitivity, skin peeling.

    Special senses - Conjunctivitis, deafness, taste perversion.

    Urogenital system - Cystitis, hematuria, leukorrhea, renal calculus, interstitial nephritis, uterine bleeding irregularities.

    Additional Adverse Reactions Reported with NSAIDs

    Body as a whole - Sepsis, death.

    Cardiovascular system - Tachycardia.

    Digestive system - Gastric ulcers, gastritis, gastrointestinal bleeding, glossitis, hematemesis.

    Hemic and lymphatic system - Lymphadenopathy.

    Nervous system - Anxiety, dream abnormalities, convulsions, coma, hallucinations, meningitis, tremors, vertigo.

    Respiratory system - Respiratory depression, pneumonia.

    Urogenital system - Oliguria/polyuria, proteinuria.

    Read the entire FDA prescribing information for Lodine (Etodolac)

    &Copy; Lodine Patient Information is supplied by Cerner Multum, Inc. and Lodine Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.